approved EB-1A

Research Fellow

Neuroscience · India · 2024-02-01

Processing Time
7 days
Decision Date
2024-02-01
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 8 peer-reviewed journal articles in the field of neuroscience.

Judging (Met)

The petitioner completed at least 30 peer reviews for journals in his field.

Original Contributions (Met)

His research on synaptic dysfunction and molecular mechanisms of brain function is supported by 255 citations and expert testimony.

Why This Petition Was Approved

The case was approved based on the petitioner's record of 8 peer-reviewed journal articles and 255 citations from researchers in 27 countries. Additionally, his participation in 30 peer reviews and receipt of funding from the Department of Science and Technology (DST) of India satisfied the EB-1A criteria.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Reference Letters Independent
Evidence Submitted
  • 8 peer-reviewed journal articles (2 first-authored)
  • 255 citations from at least 27 countries
  • Completed at least 30 peer reviews
  • Research funding from the Department of Science and Technology (DST) of India
  • 4 recommendation letters from independent researchers

Similar Cases

Research Scientist

Research and Development · China

WeGreened EB-1A approved
New York 14 days 2025-08-14
The petition was approved based on 10 peer-reviewed journal articles, 409 citations, and the completion of at least 38 peer reviews. The evidence satisfied the EB-1A criteria for original contributions, scholarly articles, and judging the work of others.

Research Scientist

Research and Development · India

WeGreened EB-1A rfe approved
Texas 569 days 2025-12-15
The petition satisfied the EB-1A criteria through 18 peer-reviewed journal articles and a book chapter. The petitioner demonstrated significant influence with 432 citations and a trusted role in the field with 39 completed peer reviews. Major governmental research funding further validated the importance of his contributions to neurodegenerative disease research.

Postdoctoral Researcher

Research and Development · India

WeGreened EB-1A approved
Massachusetts 11 days 2022-01-07
The petition was approved based on 18 peer-reviewed articles and 3 book chapters which garnered 374 citations, placing the petitioner in the top 1% of cited authors in his subfields. Additionally, he completed 65 peer reviews for various journals, demonstrating his recognized expertise. The case satisfied EB-1A criteria for scholarly articles, judging, and original contributions.

Associate Professor

Research and Development · China

WeGreened EB-1A approved
609 days 2025-04-18
The petition was approved based on 25 peer-reviewed journal articles and 1 book chapter which garnered 1,121 citations, placing him in the top 1% of cited authors in his field. Additionally, he completed 33 peer reviews for journals, demonstrating his leadership and influence in shaping neuroscience research. His work's global impact was evidenced by citations from researchers in 49 different countries.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-02-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 7 days
Criteria Met 3 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist